Literature DB >> 604192

Effect of carbenoxolone sodium on human gastric acid secretion.

J H Baron.   

Abstract

Neither basal nor peak acid output changed significantly after treatment for four weeks with carbenoxolone sodium as Biogastrone tablets in patients with gastric ulcer or Duogastrone capsules in patients with duodenal ulcer.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 604192      PMCID： PMC1411647          DOI： 10.1136/gut.18.9.721

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  8 in total

1.  [Effect of carbenoxolone and deglycyrhizinized succus liquiritiae on plasma cortisol in healthy subjects].

Authors:  E U Baas; K Sinterhauf; K H Holtermüller; G Noé; D Lommer
Journal:  Verh Dtsch Ges Inn Med       Date:  1975

2.  A double-blind study of the effect of carbenoxolone sodium in the treatment of gastric ulcer.

Authors:  P Geismar; J Mosbech; J Myren
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

3.  Gastric secretion in a healthy man, 1949-69.

Authors:  J H Baron
Journal:  Lancet       Date:  1970-09-12       Impact factor: 79.321

4.  Effect of low dosage of carbenoxolone sodium on gastric ulcer healing and acid secretion.

Authors:  J B Cocking; J N MacCaig
Journal:  Gut       Date:  1969-03       Impact factor: 23.059

5.  A trial of carbenoxolone sodium in the treatment of gastric ulceration.

Authors:  S Bank; I N Marks; P E Palmer; A Groll; E van Eldik
Journal:  S Afr Med J       Date:  1967-03-25

6.  The effect of carbenoxolone on changes in canine and human gastric mucosa caused by taurocholate and ethanol.

Authors:  M J Gordon; P O'Brien; J J Skillman; W Silen
Journal:  Surgery       Date:  1975-05       Impact factor: 3.982

7.  Studies of basal and peak acid output with an augmented histamine test.

Authors:  J H BARON
Journal:  Gut       Date:  1963-06       Impact factor: 23.059

8.  AN ASSESSMENT OF THE AUGMENTED HISTAMINE TEST IN THE DIAGNOSIS OF PEPTIC ULCER. CORRELATIONS BETWEEN GASTRIC SECRETION, AGE AND SEX OF PATIENTS, AND SITE AND NATURE OF THE ULCER.

Authors:  J H BARON
Journal:  Gut       Date:  1963-09       Impact factor: 23.059
  8 in total
  6 in total

1.  Effect of carbenoxolone on the biological activity of nitric oxide: relation to gastroprotection.

Authors:  A Dembinska-Kiec; D Pallapies; T Simmet; B M Peskar; B A Peskar
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

2.  Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol).

Authors:  J H Baron; J Barr; J Batten; R Sidebotham; J Spencer
Journal:  Gut       Date:  1986-05       Impact factor: 23.059

Review 3.  Mucosal coating agents and other nonantisecretory agents. Are they cytoprotective?

Authors:  P H Guth
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

4.  Antiulcerogenic activity of chlorogenic acid in different models of gastric ulcer.

Authors:  André T Shimoyama; José Roberto Santin; Isabel D Machado; Ana Mara de Oliveira e Silva; Illana L Pereira de Melo; Jorge Mancini-Filho; Sandra H P Farsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-06       Impact factor: 3.000

5.  Assessment of some Herbal Drugs for Prophylaxis of Peptic Ulcer.

Authors:  Ahmed A Gohar; Ahmed A Zaki
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

6.  Ulcer healing and mechanism(s) of action involved in the gastroprotective activity of fractions obtained from Syngonanthus arthrotrichus and Syngonanthus bisulcatus.

Authors:  Leônia Maria Batista; Gedson Rodrigues De Morais Lima; Ana Beatriz Albino De Almeida; Luciana De Pietro Magri; Tamara Regina Calvo; Anderson Luiz Ferreira; Cláudia Helena Pellizzon; Clélia Akiko Hiruma-Lima; Wagner Vilegas; Paulo Takeo Sano; Alba Regina Monteiro Souza Brito
Journal:  BMC Complement Altern Med       Date:  2015-10-29       Impact factor: 3.659
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.